Latest Health News

Biome Australia has reported record-breaking sales revenue for FY25, driven by strong domestic demand and promising international expansion. The company is on track to deliver its first full-year net profit and meet ambitious growth targets.

The Munro Climate Change Leaders Fund Active ETF has announced a substantial final distribution of 312.98 cents per unit for the fiscal year ending June 2025, highlighting its ongoing commitment to delivering returns amid climate-focused investments.

Proteomics International, alongside key partners, is investing $6 million to expand the WA Proteomics Facility, aiming to establish a nationally accredited platform for industrial-scale protein biomarker analysis in medicine and agriculture.

Next Science Limited has agreed to sell most of its assets to Demetra Holdings for US$50 million, with plans to return an estimated US$30 million net proceeds to shareholders pending approval.

Health and Plant Protein Group Ltd (HPP) reveals ongoing confidential discussions on corporate opportunities and reaffirms plans to return surplus assets to shareholders.

Lightning Minerals Ltd has resumed trading on the ASX following its announcement of a proposed acquisition and capital raising, signaling renewed investor interest.

Vinyl Group has secured a $1.5 million revolving credit facility from Songtradr and proposed converting historical liabilities into equity, aiming to boost its balance sheet and accelerate growth on its Vinyl.com platform.

Vitasora Health has expanded its partnership with The Physician Alliance Corporation from a pilot to a multi-year value-based care contract covering up to 15,000 Medicare patients, unlocking significant new revenue streams tied to patient outcomes.

BlinkLab has secured US Institutional Review Board approval to proceed with the main phase of its FDA 510(k) trial for an AI-powered autism diagnostic tool, marking a key step toward regulatory clearance.

Microba Life Sciences invites eligible shareholders to participate in a $2 million Share Purchase Plan at $0.09 per share, matching recent institutional pricing and including free attaching options. The capital raise aims to accelerate clinical adoption and push the company towards regional break-even.

Anagenics Limited’s licensed brand Bouf Haircare is outperforming expectations with strong early sales and promising royalty returns, signaling robust growth potential for the company’s intellectual property portfolio.

Oceania Healthcare’s CEO delivered a confident first AGM address highlighting robust sales growth, operational efficiencies, and a refreshed strategic vision focused on care quality and sustainability.